In recent years, several observational studies have suggested that GLP-1 drugs may be associated with lower risks for certain cancers or improved outcomes among cancer survivors
Most people dont have this issue, but for those who do, it can feel unsettling. According to Hosam Hmoud, MD, cardiology fellow at Northwell Lenox Hill Hospital, while the research and clinical trials we have so far on Ozempic and other GLP-1s dont include heart palpitations or arrhythmias as side effects, some studies have actually shown the opposite
[1] [3] Current evidence suggests that dulaglutide and extended-release formulations generally demonstrate lower rates of nausea compared to twice-daily exenatide or higher doses of semaglutide and liraglutide used for weight management, though individual responses vary considerably
L-Carnitine in the human body It occurs naturally in the human body, with a particularly high content in the heart and skeletal muscles
In particular, the studies only enlisted people who previously failed dieting and also recruited people at the 95th percentile for BMI